z-logo
open-access-imgOpen Access
Response to Pyrotinib in a Patient with Metastatic Bladder Urothelial Carcinoma Harboring HER2 V842I Mutation: A Case Report
Author(s) -
Suyao Li,
Qing Liu,
Mengling Liu,
Tianshu Liu
Publication year - 2022
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s365951
Subject(s) - medicine , mutation , cancer research , tyrosine kinase , metastasis , tyrosine kinase inhibitor , bladder cancer , oncology , cancer , biology , receptor , gene , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom